General Information of Drug (ID: DM5YF4M)

Drug Name
Droxidopa Drug Info
Synonyms
droxidopa; 23651-95-8; L-DOPS; Northera; (2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid; threo-Dopaserine; 3916-18-5; DOPS; DL-threo-DOPS; L-Threodops; DL-threo-3,4-Dihydroxyphenylserine; DL-threo-Droxidopa; DL-threo-Dihydroxyphenylserine; UNII-J7A92W69L7; SM 5688; CHEBI:31524; Droxidopa (L-DOPS); threo-beta,3-Dihydroxy-DL-tyrosine; EINECS 223-480-5; beta,3-Dihydroxy-DL-tyrosine threo-; BRN 2852792; L-threo-dihydroxyphenylserine; DL-threo-3-(3,4-Dihydroxyphenyl)serine; Serine, 3-(3,4-dihydroxyphenyl)-, DL-threo-
Indication
Disease Entry ICD 11 Status REF
Chronic fatigue syndrome 8E49 Approved [1]
Neurogenic orthostatic hypotension 8D87.0Y Approved [2]
Pure autonomic failure Approved [1]
Cross-matching ID
PubChem CID
92974
ChEBI ID
CHEBI:31524
CAS Number
CAS 23651-95-8
TTD Drug ID
DM5YF4M
INTEDE Drug ID
DR0552
ACDINA Drug ID
D00219

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
Drug Status:
Approved Drug(s)
Drug(s) Metabolized By DOPA decarboxylase (DDC)
Drug Name Drug ID Indication ICD 11 Highest Status REF
L-Tryptophan DMIBH7M Depression 6A70-6A7Z Approved [4]
Levodopa DMN3E57 Parkinson disease 8A00.0 Approved [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
DOPA decarboxylase (DDC) Main DME DETK9CN DDC_HUMAN Substrate [3]

References

1 Droxidopa FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7391).
3 L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug. Cardiovasc Drug Rev. 2006 Fall-Winter;24(3-4):189-203.
4 Origin and metabolism of serotonin. J Cardiovasc Pharmacol. 1990;16 Suppl 3:S1-7.
5 Complexity of dopamine metabolism. Cell Commun Signal. 2013 May 17;11(1):34.